Nektar Therapeutics (NKTR) Insider Trading & Ownership $25.84 +0.08 (+0.31%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Nektar Therapeutics (NASDAQ:NKTR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.71%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$241.48K Get NKTR Insider Trade Alerts Want to know when executives and insiders are buying or selling Nektar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NKTR Insider Buying and Selling by Quarter Nektar Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/19/2025Howard W RobinCEOSell1,547$10.05$15,547.35 5/19/2025Jonathan ZalevskyInsiderSell714$10.05$7,175.70 5/19/2025Mark Andrew WilsonInsiderSell666$10.05$6,693.30 2/19/2025Howard W RobinCEOSell1,584$15.15$23,997.60 2/19/2025Jonathan ZalevskyInsiderSell686$15.15$10,392.90 12/23/2024Mark Andrew WilsonInsiderSell2,226$13.50$30,051.00 12/19/2024Jonathan ZalevskyInsiderSell3,407$14.10$48,038.70 12/17/2024Howard W RobinCEOSell3,133$15.15$47,464.95 11/19/2024Howard W RobinCEOSell1,085$15.15$16,437.75 11/19/2024Jonathan ZalevskyInsiderSell519$15.15$7,862.85 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/19/2024Howard W RobinCEOSell992$19.20$19,046.40 8/19/2024Jonathan ZalevskyInsiderSell457$19.20$8,774.40 (Data available from 1/1/2013 forward) NKTR Insider Trading Activity - Frequently Asked Questions Who is on Nektar Therapeutics' Insider Roster? The list of insiders at Nektar Therapeutics includes Deep Track Capital, Lp, Howard W Robin, Jillian B Thomsen, Jonathan Zalevsky, Karin Eastham, Mark Andrew Wilson, Myriam Curet, Robert Chess, and Roy A Whitfield. Learn more on insiders at NKTR. What percentage of Nektar Therapeutics stock is owned by insiders? 3.71% of Nektar Therapeutics stock is owned by insiders. Learn more on NKTR's insider holdings. Which Nektar Therapeutics insiders have been selling company stock? The following insiders have sold NKTR shares in the last 24 months: Deep Track Capital, Lp ($99,671.10), Howard W Robin ($190,583.40), Jonathan Zalevsky ($113,511.30), Mark Andrew Wilson ($36,744.30), Myriam Curet ($3,001.50), and Robert Chess ($23,400.00). How much insider selling is happening at Nektar Therapeutics? Insiders have sold a total of 29,821 Nektar Therapeutics shares in the last 24 months for a total of $466,911.60 sold. More Insider Trading Tools from MarketBeat Related Companies PCRX Insider Buying OMER Insider Buying ASMB Insider Buying CPIX Insider Buying LLY Insider Buying JNJ Insider Buying ABBV Insider Buying MRK Insider Buying PFE Insider Buying BMY Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest3 Summer Stocks With Insider Buying and Analyst Support This page (NASDAQ:NKTR) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nektar Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Nektar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NKTR Stock Alerts